Study suggests new combination treatment against relapsed head and neck cancer
The five-year survival rate for locally-advanced head and neck cancer is only 46 percent, even with treatments including surgery, radiation, chemotherapy and/or genetically targeted treatments such as cetuximab. Often, the ...
Jun 6, 2018